UNSPSC 51172114: Amifloverine

This classification denotes an antispasmotic agent with the molecular formula C16H27NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X154DLC3EY, chemically known as 2-(3,5-diethoxyphenoxy)triethylamine but generally known as amifloverine, which bears US NIH Compound Identifier 168913. European Medicines Agency schedules Amifloverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05429MIG.

UNSPSC 51172114 Amifloverine, a Commodity code, does not align with state and local procurement activity captured in recent opportunities. The three most recent postings under this code cover offender drug testing specimen collection (Collin County, Texas), a therapeutic pharmacy initiative direct-to-manufacturer program (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations reference amifloverine or any pharmaceutical active ingredient by name; the code's nominal scope does not match the work actually being bought. The opportunities instead reflect broader procurement of drug testing services, pharmacy benefit management infrastructure, and wholesale pharmaceutical supply arrangements, none of which targets a specific pharmaceutical substance.

With no solicitations actually procuring amifloverine under this code in the source materials, the code shows little relevant recent activity for pursuit. Business development professionals should verify whether amifloverine is actively solicited under this or a different UNSPSC code before committing resources to this category.